NIFES will invest in a new LCMS instrument for measuring eicosanoids and other biomarkers in different kind of samples (bio-fluids, tissues, etc.). We are looking for a triple quadrupole instrument that allows quantifying human and animal samples at normal endogenous levels (≤ pigogram levels).